Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hyperthermia
Comorbidity C0024299|lymphoma
Sentences 16
PubMedID- 23672349 Significant improvements in the lymphoma subscale (including symptoms of pain, fever, itching, fatigue, weight loss, loss of appetite, and other patient concerns), fact-general, fact-lym trial outcome index, and fact-lym total were also observed with ruxolitinib versus bat starting at week 8 and continuing thereafter.
PubMedID- 22989822 Clinical features of 66 lymphoma patients presenting with a fever of unknown origin.
PubMedID- 26291417 Usefulness of random skin biopsy as a diagnostic tool of intravascular lymphoma presenting with fever of unknown origin.
PubMedID- 26463422 We observed a lymphoma in a patient with q fever that prompted us to investigate the association between the two diseases.
PubMedID- 22332684 Intravascular large b-cell lymphoma, a cause of fever of unknown origin in the elderly.
PubMedID- 24317848 Conclusions: this observational study suggested that adjunctive g-csf may confer clinical benefits among solid tumor and lymphoma patients with established febrile neutropenia.
PubMedID- 24684228 History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in patients with non-hodgkin lymphoma not receiving granulocyte colony-stimulating factor prophylaxis.
PubMedID- 23255844 Use of zidovudine or trimethoprim/sulfamethoxazole or bone marrow involvement of lymphoma was not associated with neutropenic fever or febrile prolonged neutropenia (data not shown).
PubMedID- 22117311 [two cases of successfully treated intravascular lymphoma presenting with fever and dyspnea].
PubMedID- 21413829 Empiric sc therapy was found to be as effective as carbapenem monotherapy in pediatric febrile neutropenic patients with lymphoma and solid tumors.
PubMedID- 26027994 Hiv-negative primary bone marrow hodgkin lymphoma manifesting with a high fever associated with hemophagocytosis as the initial symptom: a case report and review of the previous literature.
PubMedID- 23917942 The male patient, who was 37 years of age and undergoing therapy for non-hodgkin's lymphoma, was admitted with cough, fever, dyspnea and acute hypoxemic respiratory failure.
PubMedID- 26532567 Cost-effectiveness analysis of granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced febrile neutropenia in patients with non-hodgkin's lymphoma in greece.
PubMedID- 25252614 Background: the primary objective was to describe the total direct inpatient costs among solid tumor and lymphoma patients with chemotherapy-induced febrile neutropenia (fn) and the factors that were associated with higher direct cost.
PubMedID- 26111699 [muscle tissue lymphoma presenting only with fever of unknown origin: a case report and literature review].
PubMedID- 22972488 Primary prophylaxis with granulocyte colony-stimulating factor (gcsf) reduces the incidence of febrile neutropenia in patients with non-hodgkin lymphoma (nhl) receiving chop chemotherapy treatment without adversely affecting their quality of life: cost-benefit and quality of life analysis.

Page: 1